APeX Cancer Research  - Direct Oxygen Infusion Protocol 

 Click Button for Background:

 Click for APeX and Health: 

 Click Button to watch video:

Click to  Buy APeX:    

Click for APeX Research successes:  

APeX Institute is invited to present the game-changing science of APeX Focused Oxygen Infusion Protocol to the prestigious main stream 2018 International Cancer Treatment Conference in Oslo, Norway.

Actual Case Histories from redacted formal medical records written by independent oncologists note the power of APeX Focused Oxygen Infusion Protocol.

APeX Institute  Founder-Director Bill Chastain's background and motivation for helping others.

 Click Button for Book Hi-Lites: 

 Click Button for More APeX News: 

Information on this website is not intended to promote any product as a treatment or cure for any disease or medical condition.
Medal presented by Oregon Secretary of State, Dennis Richardson.

With Hypoxia identified as a trigger for cancer and many diseases,  APeX Focused  Direct

Oxygen Infusion  delivers an overload of active oxygen molecules directly into  cancer and disease cells to eliminate effects of hypoxia. 

  APeX Institute was recently awarded this prestigious Humanitarian 

Tiny robots  travel inside the body, hunting and killing disease cells with laser-like precision. Science fiction? Read how APeX can target individual disease cells with laser like precision.

Merck's research proved that hypoxia, or lack of Oxygen, promotes the start and spread of cancer - but after spending $100 million and 10 years on research, Merck's anti-hypoxia drug failed clinical trials and the program was abandoned.

​​​​Read about APeX as a virtual Fountain of Youth,  and about an amazing recovery - how one person overcame  a crippling spine injury with dedication, hard work - and APeX.

 Click Button o read Actual Cases:

Video:  Famous Beverly Hills physician presents "APeX - Cutting Edge Cancer Treatment" at the  Cancer Control Society Convention in Los Angeles.

Contact:  wpchastain@gmail.com    Direct phone: 503-757-8444